Potential peripheral biomarkers for the diagnosis of Alzheimer's disease

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Patel, Seema ^a   Shah, Raj J ^a   Coleman, Paul ^a   Sabbagh, Marwan ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; COMPLEMENT FACTOR H; GLIAL FIBRILLARY ACIDIC PROTEIN;

ALZHEIMER DISEASE; DIAGNOSTIC APPROACH ROUTE; DISEASE PREDISPOSITION; EPIGENETICS; GENOMICS; HUMAN; METABOLOMICS; PRIORITY JOURNAL; PROTEOMICS; REVIEW;

EID: 84855261953     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/572495     Document Type: Review

References (44)

1. Blennow K., Hampel H., CSF markers for incipient Alzheimer's disease The Lancet Neurology 2003 2 10 605 613 (Pubitemid 37162569)
2. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association, The National Institute on Aging, Consensus report of the Working Group on: molecular and biochemical markers of Alzheimer's disease Neurobiology of Aging 1998 19 109 116
3. Hampel H., Frank R., Broich K., Teipel S. J., Katz R. G., Hardy J., Herholz K., Bokde A. L. W., Jessen F., Hoessler Y. C., Sanhai W. R., Zetterberg H., Woodcock J., Blennow K., Biomarkers for alzheimer's disease: academic, industry and regulatory perspectives Nature Reviews Drug Discovery 2010 9 7 560 574
4. Roher A. E., Esh C. L., Kokjohn T. A., Castao E. M., Van Vickle G. D., Kalback W. M., Patton R. L., Luehrs D. C., Daugs I. D., Kuo Y. M., Emmerling M. R., Soares H., Quinn J. F., Kaye J., Connor D. J., Silverberg N. B., Adler C. H., Seward J. D., Beach T. G., Sabbagh M. N., Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease Alzheimer's and Dementia 2009 5 1 18 29
5. Bermejo-Pareja F., Antequera D., Vargas T., Molina J., Carro E., Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study BMC Neurology 2010 10 108
6. Boston P. F., Gopalkaje K., Manning L., Middleton L., Loxley M., Developing a simple laboratory test for Alzheimer's disease: measuring acetylcholinesterase in salivaa pilot study International Journal of Geriatric Psychiatry 2008 23 4 439 440 (Pubitemid 351566343)
7. Sayer R., Law E., Connelly P. J., Breen K. C., Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors Clinical Biochemistry 2004 37 2 98 104 (Pubitemid 38077159)
8. Thambisetty M., Lovestone S., Blood-based biomarkers of Alzheimers disease: challenging but feasible Biomarkers in Medicine 2010 4 1 65 79
9. Lukens J. N., van Deerlin V., Clark C. M., Xie S. X., Johnson F. B., Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease Alzheimer's and Dementia 2009 5 6 463 469
10. Butcher J., Urine tests for Alzheimer's disease-are they fool's gold? Lancet Neurology 2007 6 2 106 107 (Pubitemid 46097538)
11. de La Monte S. M., Wands J. R., The AD7c-NTP neuronal thread protein biomarker for detecting Alzheimer's disease Journal of Alzheimer's Disease 2001 3 3 345 353 (Pubitemid 32577639)
12. Corneveaux J. J., Myers A. J., Allen A. N., Pruzin J. J., Ramirez M., Engel A., Nalls M. A., Chen K., Lee W., Chewning K., Villa S. E., Meechoovet H. B., Gerber J. D., Frost D., Benson H. L., O'Reilly S., Chibnik L. B., Shulman J. M., Singleton A. B., Craig D. W., Van Keuren-Jensen K. R., Dunckley T., Bennett D. A., de Jager P. L., Heward C., Hardy J., Reiman E. M., Huentelman M. J., Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals Human Molecular Genetics 2010 19 16 3295 3301
13. Jones L., Harold D., Williams J., Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease Biochimica et Biophysica Acta 2010 1801 8 754 761
14. Bertram L., McQueen M. B., Mullin K., Blacker D., Tanzi R. E., Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nature Genetics 2007 39 1 17 23 (Pubitemid 46026496)
15. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 1993 261 5123 921 923 (Pubitemid 23275809)
16. Utermann G., Langenbeck U., Beisiegel U., Weber W., Genetics of the apolipoprotein E system in man American Journal of Human Genetics 1980 32 3 339 347 (Pubitemid 11105559)
17. Saunders A. M., Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses Journal of Neuropathology and Experimental Neurology 2000 59 9 751 758
18. Song F., Poljak A., Smythe G. A., Sachdev P., Plasma biomarkers for mild cognitive impairment and Alzheimer's disease Brain Research Reviews 2009 61 2 69 80
19. Sorli J. V., Corella D., Frances F., The effect of APOE polymorphism on HDL-C concentrations depends on the cholesterol ester transfer protein gene variation in a Southern European population Clinica Chimica 2006 336 196 203 (Pubitemid 43330983)
20. Berlau D. J., Corrada M. M., Head E., Kawas C. H., ApoE 2 is associated with intact cognition but increased Alzheimer pathology in the oldest old Neurology 2009 72 9 829 834
21. Kulminski A. M., Ukraintseva S. V., Arbeev K. G., Manton K. G., Oshima J., Martin G. M., Il'yasova D., Yashin A. I., Health-protective and adverse effects of the apolipoprotein E 2 allele in older men Journal of the American Geriatrics Society 2008 56 3 478 483 (Pubitemid 351327926)
22. Kounnas M. Z., Moir R. D., Rebeck G. W., Bush A. I., Argraves W. S., Tanzi R. E., Hyman B. T., Strickland D. K., LDL receptor-related protein, a multifunctional apoE receptor, binds secreted -amyloid precursor protein and mediates its degradation Cell 1995 82 2 331 340
23. Miyata M., Smith J. D., Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and -amyloid peptides Nature Genetics 1996 14 1 55 61 (Pubitemid 26301547)
24. Mahley R., Weisgraber K., Huang Y., Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2006 103 15 5644 5651
25. Reiman E. M., Webster J. A., Myers A. J., Hardy J., Dunckley T., Zismann V. L., Joshipura K. D., Pearson J. V., Hu-Lince D., Huentelman M., Craig D. W., Coon K. D., Liang W. S., Herbert R. H., Beach T., Rohrer K. C., Zhao A. S., Leung D., Bryden L., Marlowe L., Kaleem M., Mastroeni D., Grover A., Heward C. B., Ravid R., Rogers J., Hutton M. L., Melquist S., Petersen R. C., Alexander G. E., Caselli R., Kukull W., Papassotiropoulos A., Stephan D. A., GAB2 alleles modify Alzheimer's risk in APOE 4 carriers Neuron 2007 54 5 713 720 (Pubitemid 46843528)
26. Liang W. S., Chen K., Lee W., Sidhar K., Corneveaux J. J., Allen A. N., Myers A., Villa S., Meechoovet B., Pruzin J., Bandy D., Fleisher A. S., Langbaum J. B. S., Huentelman M. J., Jensen K., Dunckley T., Caselli R. J., Kaib S., Reiman E. M., Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOE 4 carriers NeuroImage 2011 54 3 1896 1902
27. Yu C. E., Seltman H., Peskind E. R., Galloway N., Zhou P. X., Rosenthal E., Wijsman E. M., Tsuang D. W., Devlin B., Schellenberg G. D., Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association Genomics 2007 89 6 655 665 (Pubitemid 46719797)
28. Roses A. D., Lutz M. W., Amrine-Madsen H., Saunders A. M., Crenshaw D. G., Sundseth S. S., Huentelman M. J., Welsh-Bohmer K. A., Reiman E. M., A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease Pharmacogenomics Journal 2010 10 5 375 384
29. Grossman I., Lutz M. W., Crenshaw D. G., Saunders A. M., Burns D. K., Roses A. D., Alzheimer's disease: diagnostics, prognostics and the road to prevention The EPMA Journal 2010 1 293 303
30. Abraham R., Moskvina V., Sims R., A genome-wide association study for late-onset Alzheimer's disease using DNA pooling BMC Medical Genomics 2008 1 44
31. Ray S., Britschgi M., Herbert C., Takeda-Uchimura Y., Boxer A., Blennow K., Friedman L. F., Galasko D. R., Jutel M., Karydas A., Kaye J. A., Leszek J., Miller B. L., Minthon L., Quinn J. F., Rabinovici G. D., Robinson W. H., Sabbagh M. N., So Y. T., Sparks D. L., Tabaton M., Tinklenberg J., Yesavage J. A., Tibshirani R., Wyss-Coray T., Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins Nature Medicine 2007 13 11 1359 1362 (Pubitemid 350073592)
32. Bhutra S., Proteomics of Alzheimers Disease. http://biochem118.stanford. edu/Projects/200820Autumn/Steven.pdf
33. Graff-Radford N. R., Crook J. E., Lucas J., Boeve B. F., Knopman D. S., Ivnik R. J., Smith G. E., Younkin L. H., Petersen R. C., Younkin S. G., Association of low plasma A 42/A 40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease Archives of Neurology 2007 64 3 354 362 (Pubitemid 46425689)
34. Schupf N., Tang M. X., Fukuyama H., Manly J., Andrews H., Mehta P., Ravetch J., Mayeux R., Peripheral A subspecies as risk biomarkers of Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2008 105 37 14052 14057
35. Locascio M. F., Fukumoto H., Yap L., Bottiglieri T., Growdon J. H., Hyman B. T., Irizarry M. C., Plasma amyloid -protein and C-reactive protein in relation to the rate of progression of Alzheimer disease Archives of Neurology 2008 65 6 776 785 (Pubitemid 351831455)
36. van Oijen M., Hofman A., Soares H. D., Koudstaal P. J., Breteler M. M., Plasma A 1-40 and A 1-42 and the risk of dementia: a prospective case-cohort study Lancet Neurology 2006 5 8 655 660 (Pubitemid 44062411)
37. Hye A., Lynham S., Thambisetty M., Causevic M., Campbell J., Byers H. L., Hooper C., Rijsdijk F., Tabrizi S. J., Banner S., Shaw C. E., Foy C., Poppe M., Archer N., Hamilton G., Powell J., Brown R. G., Sham P., Ward M., Lovestone S., Proteome-based plasma biomarkers for Alzheimer's disease Brain 2006 129 11 3042 3050 (Pubitemid 44684524)
38. Hansson O., Zetterberg H., Buchhave P., Londos E., Blennow K., Minthon L., Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study Lancet Neurology 2006 5 3 228 234 (Pubitemid 43238346)
39. Moraga F., Janciauskiene S., Activation of primary human monocytes by the oxidized form of 1- antitrypsin Journal of Biological Chemistry 2000 275 11 7693 7700 (Pubitemid 30159672)
40. Padmanabhan J., Levy M., Dickson D. W., Potter H., 1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons Brain 2006 129 11 3020 3034 (Pubitemid 44684522)
41. Soares H. D., Chen Y., Sabbagh M., Rohrer A., Schrijvers E., Breteler M., Identifying early markers of alzheimer's disease using quantitative multiplex proteomic immunoassay panels Annals of the New York Academy of Sciences 2009 1180 56 67
42. Siegmund K. D., Connor C. M., Campan M., Long T. L., Weisenberger D. J., Biniszkiewicz D., Jaenisch R., Laird P. W., Akbarian S., DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons PLoS ONE 2007 2 9, article e895
43. Wang S. C., Oeize B., Schumacher A., Age-specific epigenetic drift in late-onset Alzheimer's disease PLoS ONE 2008 3 7
44. Kaddurah-Daouk R., Rozen S., Matson W., Han X., Hulette C. M., Burke J. R., Doraiswamy P. M., Welsh-Bohmer K. A., Metabolomic changes in autopsy-confirmed Alzheimer's disease Alzheimer's and Dementia 2011 7 3 309 317